Award
NIH Reporter #5R21CA296062-02
Sequential infection of laboratory mice for enhanced cancer and immunotherapy translation
Recipient
Not specified
Award Amount
$138,848.00
Ceiling
$138,848.00
Awarded
June 19, 2026
Identifier
5R21CA296062-02
Research grant awarded by the National Cancer Institute to develop a mouse model for cancer and immunotherapy translation, with an award amount of $138,848.
Description
This is a research grant project focusing on developing a mouse model for enhanced cancer and immunotherapy translation through sequential infection protocols. The project is funded by the National Cancer Institute, NIH, with a total award amount of $138,848 for fiscal year 2026. The project start date is August 1, 2025, and end date is July 31, 2027.